Polymorphs are molecules that have different molecular packing arrangements despite identical chemical compositions. In a recent paper, researchers at GlaxoSmithKline (GSK) and the Cambridge Crystallographic Data Centre (CCDC) combined their proprietary (GSK) and published (CCDC) datasets to better train machine learning (ML) models to predict stable polymorphs to use in new drug candidates.
How to develop new drugs based on merged datasets
October 2, 2021
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022